Title

Safety and Efficacy of Apremilast Through 104 Weeks in Patients With Moderate to Severe Psoriasis Who Continued on Apremilast or Switched From Etanercept Treatment: Findings From the LIBERATE Study.

Document Type

Journal Article

Publication Date

12-8-2017

Journal

Journal of the European Academy of Dermatology and Venereology : JEADV

DOI

10.1111/jdv.14738

Peer Reviewed

1